Seminars in Radiation Oncology
Volume 18, Issue 1 , Pages 67-72 , January 2008

Measuring Health-Related Quality of Life Consequences From Primary Treatment for Early-Stage Prostate Cancer

  • Savita V. Dandapani, PhD

      Affiliations

    • Harvard Medical School, Boston, MA.
    • ,
  • Martin G. Sanda, MD

      Affiliations

    • Harvard Medical School, Boston, MA.
    • Beth Israel Deaconess Medical Center, Boston, MA.
    • Corresponding Author InformationAddress reprint requests to Martin G. Sanda, MD, Division of Urology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Rabb 440, Boston, MA 02215.

References 

  1. Bolla M, Gonzalez D, Warde P, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 1997;337:295–300
  2. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–1984
  3. Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50:920–928
  4. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135
  5. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002–1012
  6. Downs TM, Sadetsky N, Pasta DJ, et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer—Data from CaPSURE. J Urol. 2003;170:1822–1827
  7. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst. 2004;96:1358–1367
  8. Madalinska JB, Essink-Bot ML, de Koning HJ, et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19:1619–1628
  9. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the Expanded Prostate cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905
  10. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772–2780
  11. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003;21:3979–3986
  12. Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001;39:1118–1130
  13. Joly F, Brune D, Couette JE, et al. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol. 1998;9:751–757

PII: S1053-4296(07)00092-6

doi: 10.1016/j.semradonc.2007.10.001

Seminars in Radiation Oncology
Volume 18, Issue 1 , Pages 67-72 , January 2008

Article Tools